US Sunshine Act

The Sunshine Act requires drug and device makers to report any payments or transfers of value they make to US Licensed physicians and teaching hospitals. The Sunshine Act was created because of the inherent risk of conflicts related to the relationships between doctors and companies in the drug and medical device industries. ​Companies found to be unknowingly non-compliant with the Sunshine Act can face civil penalties of between $1,000 and $10,000 for each payment, transfer of value, or ownership or investment interest not reported timely, accurately, or completely. When it comes to knowing non-compliance, the range increases to between $10,000 and $100,000, subject to an annual cap of $1,000,000. That’s a total risk of $1,150,000 every year! Simply, if you are active in the healthcare industry, you need an effective Sunshine Act training program.